Mount Sinai Health System Inc.
SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for[...]
09/04/2024 | News release | Distributed by Public on 09/03/2024 23:09
Please select the service you want to use:
Smartlinks | C40 Cities Climate Leadership Group Inc. | News | International News | Environment | Politics and Policy | Advocacy Groups
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact